Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.
Sign Up to like & getrecommendations! Published in 2019 at "ESC Heart Failure"
DOI: 10.1002/ehf2.12513
Abstract: Ivabradine has been approved in heart failure with reduced ejection fraction (HFrEF) and elevated heart rate despite guideline‐directed medical therapy (GDMT) to reduce cardiovascular (CV) death and hospitalization for worsening HF. The median value of… read more here.
Keywords: effects ivabradine; heart rate; heart; heart failure ... See more keywords
EFFECTS OF IVABRADINE ON SYMPATHETIC OVERDRIVE AND ARTERIAL STIFFENING IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME: A 6 MONTH FOLLOW-UP STUDY
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(18)32348-9
Abstract: Hypertension and metabolic syndrome are related to sympathetic overdrive and arterial stiffening, while there are no data whether ivabradine modulates sympathetic activity and vascular abnormalities in this setting. The aim of this study was to… read more here.
Keywords: effects ivabradine; arterial stiffening; overdrive arterial; study ... See more keywords
Does nitric oxide mediate the effects of ivabradine in patients with heart failure?
Sign Up to like & getrecommendations! Published in 2018 at "Anatolian Journal of Cardiology"
DOI: 10.14744/anatoljcardiol.2018.61819
Abstract: Ivabradine is a pure heart rate-lowering agent and was recently approved for the treatment of heart failure (1). Ivabradine was approved for use in Europe by the European Medicines Agency for treating patients with heart… read more here.
Keywords: effects ivabradine; heart; heart failure; akt enos ... See more keywords